1. Hanahan, D. and Weinberg, R.A., The hallmarks of cancer, Cell, 2000, vol. 100, pp. 57–70.
2. Kanamori, Y., Kigawa, J., Itamochi, H., et al., Correlation between loss of PTEN expression and Aktphosphorylation in endometrial carcinoma, Clin. Cancer Res., 2001, vol. 7, pp. 892–895.
3. Uegaki, K., Kanamori, Y., Kigawa, J., et al., PTEN-positive and phosphorylated-Akt-negative expression is a predictor of survival for patients with advanced endometrial carcinoma, Oncol. Rep., 2005, vol. 14, pp. 389–392.
4. Tsutsui., S., Inoue, H., Yasuda, K., et al., Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast, Oncology, 2005, vol. 68, pp. 398–404.
5. Eng, C., PTEN: One gene, many syndromes, Hum Mutat., 2003, vol. 22, no. 3, pp. 183–198.